Abstract

The General Pharmaceutical Council (GPhC) received 1,118 new fitness-to-practise (FtP) concerns between July and September 2022 — the highest ever quarterly number, according to its council papers published on 4 November 2022. This was 30% higher than the 854 complaints received in the previous quarter — which was previously the highest number of concerns raised […]

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.